You searched for "simulation"
Climb every mountain!
2 August 2024
| David Lockington
Recently, on a weekend break away in the beautiful Cairngorms, I foolishly let it be known that I had never actually climbed a ‘Munro’, despite having moved from Northern Ireland to Scotland nearly 17 years ago! For the unaware, Munros...
Haag-Streit UK announces the launch of ‘Improving Outcomes’ Biometry Courses
18 July 2023
|
Research & Development
Haag-Streit UK is delighted to announce exclusive dates for two ‘Improving Outcomes’ biometry courses on Thursday 19th and Friday 20th October 2023 at our brand-new dedicated Academy facility.
Anterior and posterior capsular opacification with the Tecnis ZCBOO and AcrySof SA60AT IOL
This a randomised, controlled, prospective and double-blind study comparing the anterior capsular opacification (ACO) and posterior capsular opacification (PCO) outcomes with two types of single-piece hydrophobic acrylic intraocular lenses (IOL), and AcrySof SA60AT – Group A, and Tecnis ZCBOO –...Statins inhibit TGFβ2 mediated fibrotic response in astrocytes
1 April 2018
| Graham Wallace
|
EYE - Glaucoma
Glaucoma is a common condition where increased ocular pressure can lead to death of retinal ganglion cells due to impaired drainage of fluid from the eye. One mechanism involved in glaucoma is remodelling of the extracellular matrix at the lamina...
Visual outcome and surgical results in children with Marfan Syndrome
5 June 2020
| Ivan Yip
|
EYE - Vitreo-Retinal
Eighty-two eyes of 41 patients with a genetically proven diagnosis of Marfan syndrome were retrospectively analysed. Twenty-seven had bilateral subluxation and 14 received lensectomy. Follow-up was three years. Mean visual acuity (VA) was 0.1 ±0.7 logMAR in patients with normal...
Conjunctival inflammation in glaucoma patients
1 April 2015
| Khadijah Basheer
|
EYE - Glaucoma
Numerous studies have demonstrated that topical medications and preservatives used for the management of glaucoma can induce significant histopathologic and inflammatory changes in the ocular surface. This study describes an increased expression of major histocompatibility complex class II antigen HLA-DR,...
Part 3: The Arclight Project: Implementation workshops
2 August 2024
| Andrew Blaikie, Chimgee Chuluunkhuu, Henry E Marealle, Frank Maliko, Dechen Wangmo
|
EYE - General
In this three-part series (Click here for Part 1 and Part 2) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. The Arclight Project aims to support and enhance the...
How to be ‘appy’ on call: a brief guide to mobile phone applications for the on-call ophthalmologist
1 December 2022
| Madeleine Corkery-Hayward, Ryian Mohamed, Harry Petrushkin, David Haider
|
EYE - General
One of the unexpected outcomes of the COVID-19 pandemic has been an increased reliance and integration of computer technology within hospital medicine. The need for stricter infection control policies during and after lockdown has seen a boom in technology utilisation....
Choroideremia in women
2 June 2025
| Ian Reekie
|
EYE - Vitreo-Retinal
The authors report a questionnaire-based study of female carriers of choroideremia, an X-linked inherited chorioretinal dystrophy. As an X-linked condition the full clinical features are predominantly seen in men but a proportion of women suffer some morbidity, likely due to...
How do you solve the problem of trachoma in Ethiopia?
4 October 2023
| Alemayehu Sisay
|
EYE - Cornea
Background Trachoma is one of the oldest diseases known to humankind and the leading infectious cause of blindness worldwide. Spread by the bacterium chlamydia trachomatis, it is transmitted through contact with the eyes, eyelids and nose of those infected. The...
Germline testing for uveal melanoma
4 December 2023
| Ian Reekie
|
EYE - Pathology, EYE - Oncology
|
BAP1, Uveal melanoma, genetic counselling, hereditary cancer, mainstreaming, service delivery
The authors present a study of 114 consecutive patients presenting with uveal melanoma. Between 1 December 2019 and 1 November 2021 all patients over 18-years-old presenting to their centre with uveal melanoma were offered germline testing for variants in BAP1,...
UK Paediatric Glaucoma Society Annual Meeting 2025
24 January 2025
by Hussain Aluzri, Junior Glaucoma Cinical Research Fellow, Birmingham Midland Eye Centre, UK. The UKPGS 2025 conference was another resounding success, held on 24 January 2025 at the Cavendish Conference Centre, London. The event commenced with an opening address by...